SCHEMBL24519085

SCHEMBL24519085

c1ccc2c(c1)ccc1oc3ccc4oc5ccc(-c6c7ccccc7c(-c7ccc8oc9ccccc9c8c7)c7ccccc67)cc5c4c3c12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.44
MAPT P10636 3/20 0.44
HPGD P15428 3/20 0.44
TDP1 Q9NUW8 3/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
GLA P06280 2/20 0.44
TSHR P16473 1/20 0.44
HTT P42858 1/20 0.44
HSD17B10 Q99714 1/20 0.44
ALDH1A1 P00352 5/20 0.44
NPC1 O15118 4/20 0.44
RAB9A P51151 4/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
HNF4A P41235 1/20 0.43
ABCG2 Q9UNQ0 3/20 0.42
PAX8 Q06710 2/20 0.42
AHR P35869 2/20 0.42
CYP1A1 P04798 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20127306 0.95 KDM4E (0.45) KDM4EMAPTHPGDTDP1L3MBTL1
SCHEMBL22218984 0.94 KDM4E (0.44) KDM4EMAPTHPGDTDP1L3MBTL1
SCHEMBL12768096 0.92 KDM4E (0.47) KDM4EMAPTHPGDTDP1L3MBTL1
SCHEMBL20127312 0.91 NPC1 (0.41) KDM4EMAPTHPGDTDP1L3MBTL1
SCHEMBL20127294 0.91 ABCG2 (0.44) KDM4EMAPTHPGDTDP1L3MBTL1
SCHEMBL10122694 0.91 ABCG2 (0.46) KDM4EMAPTHPGDTDP1L3MBTL1
SCHEMBL12338352 0.90 TDP1 (0.43) KDM4EMAPTHPGDTDP1L3MBTL1
SCHEMBL20127720 0.90 NPC1 (0.41) KDM4EMAPTHPGDTDP1L3MBTL1
SCHEMBL20127318 0.90 PLA2G2A (0.43) KDM4EMAPTHPGDTDP1L3MBTL1
SCHEMBL19081693 0.90 TDP1 (0.43) KDM4EMAPTHPGDTDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11367838-B2 Anthracene derivative and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2022-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11367838-B2 Anthracene derivative and organic light-emitting device comprising same CCNL2, CRY1, CYP2S1 KDM4E 3061/4885MAPT 4193/4885HPGD 2297/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.